Skip to Main Content

Advertisement

Skip Nav Destination

The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma

Clin Cancer Res (2022) 28 (12): 2669–2678.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal